001     1032187
005     20250203133217.0
024 7 _ |a 10.1016/S1470-2045(24)00315-2
|2 doi
024 7 _ |a 1470-2045
|2 ISSN
024 7 _ |a 1474-5488
|2 ISSN
024 7 _ |a 39481415
|2 pmid
024 7 _ |a WOS:001348280600001
|2 WOS
037 _ _ |a FZJ-2024-06056
082 _ _ |a 610
100 1 _ |a Bakas, Spyridon
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice
260 _ _ |a London
|c 2024
|b The Lancet Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1738146790_7914
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Technological advancements have enabled the extended investigation, development, and application of computational approaches in various domains, including health care. A burgeoning number of diagnostic, predictive, prognostic, and monitoring biomarkers are continuously being explored to improve clinical decision making in neuro-oncology. These advancements describe the increasing incorporation of artificial intelligence (AI) algorithms, including the use of radiomics. However, the broad applicability and clinical translation of AI are restricted by concerns about generalisability, reproducibility, scalability, and validation. This Policy Review intends to serve as the leading resource of recommendations for the standardisation and good clinical practice of AI approaches in health care, particularly in neuro-oncology. To this end, we investigate the repeatability, reproducibility, and stability of AI in response assessment in neuro-oncology in studies on factors affecting such computational approaches, and in publicly available open-source data and computational software tools facilitating these goals. The pathway for standardisation and validation of these approaches is discussed with the view of trustworthy AI enabling the next generation of clinical trials. We conclude with an outlook on the future of AI-enabled neuro-oncology.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Vollmuth, Philipp
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Galldiks, Norbert
|0 P:(DE-Juel1)143792
|b 2
700 1 _ |a Booth, Thomas C
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Aerts, Hugo J W L
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Bi, Wenya Linda
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Wiestler, Benedikt
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Tiwari, Pallavi
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Pati, Sarthak
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Baid, Ujjwal
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Calabrese, Evan
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Lohmann, Philipp
|0 P:(DE-Juel1)145110
|b 11
700 1 _ |a Nowosielski, Martha
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Jain, Rajan
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Colen, Rivka
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Ismail, Marwa
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Rasool, Ghulam
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Lupo, Janine M
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Akbari, Hamed
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Tonn, Joerg C
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Macdonald, David
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Vogelbaum, Michael
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Chang, Susan M
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Davatzikos, Christos
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Villanueva-Meyer, Javier E
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Huang, Raymond Y
|0 P:(DE-HGF)0
|b 25
773 _ _ |a 10.1016/S1470-2045(24)00315-2
|g Vol. 25, no. 11, p. e589 - e601
|0 PERI:(DE-600)2035574-9
|n 11
|p e589 - e601
|t The lancet / Oncology
|v 25
|y 2024
|x 1470-2045
856 4 _ |u https://juser.fz-juelich.de/record/1032187/files/post%20print.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:1032187
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)143792
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 11
|6 P:(DE-Juel1)145110
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 1
914 1 _ |y 2024
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LANCET ONCOL : 2022
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-17
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-17
915 _ _ |a IF >= 50
|0 StatID:(DE-HGF)9950
|2 StatID
|b LANCET ONCOL : 2022
|d 2024-12-17
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 0
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21